1. Seres Therapeutics (MCRB) Names Willard Dere to Board of Directors

    Seres Therapeutics (MCRB) Names Willard Dere to Board of Directors

    Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced the appointment of Willard Dere, M.D., a seasoned industry executive, to its Board of ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Willard Dere is a highly distinguished industry leader with deep clinical development and strategic industry expertise.
    2. Seres is advancing a promising pipeline of microbiome product candidates using a highly differentiated scientific approach. I am eager to contribute to the company's objective of bringing the first FDA approved microbiome products to individuals with serious diseases.
  3. Topics Mentioned